"Designing Growth Strategies is in our DNA"

Contract Manufacturing Organization (CMO) Market Size, Share & Industry Analysis, By Type (API Manufacturing, Finished Dosage Form Manufacturing (Solid Dosage Forms, Injectables, and Others), and Packaging), and Regional Forecast, 2019-2026

Region : Global | Format: PDF | Report ID: FBI102658

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The global Contract Manufacturing Organization(CMO) market size was valued at USD 92.42 billion in 2018 and is projected to reach USD 188.07 billion by 2026, exhibiting a CGR of 9.4% during the forecast period.

COVID-19 Cover

We are in process of revamping Contract Manufacturing Organization (CMO) Market with respect to COVID-19 Impact.

Request Sample

Contract Manufacturing Organization provide highly valuable services to the expanding pharmaceutical industry. Increasing demand for pharmaceutical products for the treatment of various diseases and shortages of lifesaving medicines has resulted in the growing demand for outsourcing of the manufacturing operations. CMOs follow all the regulations, have highly skilled man-power, presence of state of the art manufacturing facilities, and cost -effective service portfolio. Growing competition in the pharmaceutical sector has resulted in the utmost need of launching products as early as possible to capture pioneering position of the market. Thus, increasing need to launch products earlier, growing pricing pressure, and benefits provided by CMO’s such as reduced timelines and high quality products in low cost are some of the major drivers of the market.


MARKET TRENDS


Request a Free sample to learn more about this report.


Consolidation Wave of Pharmaceutical Contract Manufacturing Organization Still Continue


The Contract Manufacturing Organization market is highly fragmented market with presence of large number of service providers with manufacturing capacities spread across various dosage forms. However, a wave of strategic collaborations, mergers, acquisitions, and partnerships has been witnessed in these years. This is aimed by market giants to use manufacturing capabilities and expertise of locally established players to increase market share. The notable deals in contract manufacturing sector include acquisition of injectable manufacturing capabilities of Hospira Inc. in the year 2015. Moreover, a global leader in the CMO space, ‘Lonza Group AG’ acquired Capsugel S.A, in December 2016 with the aim to address needs of customers for integrated and value added solutions.


MARKET DRIVERS


Strong Growth in the Biologics Market to Mirror CMO Market Growth


With increasing prevalence of chronic diseases, the global demand for effective therapies has been on its peak. Rise in the investments in development of complex biologic molecules has created a huge need for highly proficient service providers able to deliver products with desired regulatory standards. The biologic molecules are complex and the manufacturing requires strong skills and approved manufacturing facilities. The Contract Manufacturing Organization in the market are upgrading their capabilities to serve the global need. Thus, more and more biological products are being outsourced for manufacturing and packaging activities. Expansion of the production capacities by the leading CROs from emerging nations is expected to uplift the pharmaceutical Contract Manufacturing Organization(CMO) market revenue by 2026.


Emergence of More CMOs with Expanded Manufacturing Capacities to Boost the Market


In order to address increasing demand for outsourcing, several new companies are entering the market with advanced manufacturing solutions. This is making the pharmaceutical players to believe in their technical capabilities and outsource their production to these service providers. Mid-sized or even small pharmaceutical companies now are likely to be engaged with one or more CMOs operating in the field. Thus, increasing number of Contract Manufacturing Organization entering into the space will create lucrative opportunity to promote outsourcing of the pharmaceutical activities in the near future.


MARKET RESTRAINT


Stringent Regulations and Capacity Utilization Issues to Hamper CMOs Profits


Despite growing demand for the pharmaceutical outsourcing of the products, stringent regulations pose limitations for Contract Manufacturing Organization to gain business deals. The Contract Manufacturing Organization needs to be approved by   concerned regulatory bodies and to maintain the similar standards throughout the contract period. Stringency of the regulations limits the players to offer services for respective geographic location for instance, in the U.S. The USFDA standards for approval and regular QC are known to be most stringent among others across globe.


SEGMENTATION


By Type Analysis


To know how our report can help streamline your business, Speak to Analyst


API Manufacturing Segment to Hold Dominating Share of CMO Market


Based on type, the CMO market is segmented into API manufacturing; finish product manufacturing, and packaging. The API segment dominated the CMO market in 2018. Growing demand for biologic molecules contribute to high share of the API segment. About 60% of the highly potent API i.e. HPAPI are indicated for the treatment of cancer. Growing prevalence of cancer and high demand for novel therapies are estimated to propel the API manufacturing segment growth throughout the forecast period. However, the finished formulation manufacturing segment is projected to expand at highest CAGR owing to growing outsourcing of injectable formulations witnessed in recent years. The finished formulation segment is further categorized into solid dosage forms, injectables, and others (semisolids, powders, oral liquids, and others). Among them, the injectable sub-segment is likely to dominate the finished formulations sub-segment by 2026.


REGIONAL ANALYSIS


North America Contract Manufacturing Organization(CMO) Market Size, 2018(USD billion)

To get more information on the regional analysis of this market, Request a Free sample


The contract manufacturing organization market size in North America stood at USD 32.60 billion in 2018. The market in the region is characterized by higher prevalence and diagnosis rates for lifestyle diseases, high investments in research and development, presence of large number of CMOs, and large number of companies involved in the development of biologic molecules. Europe is the second largest market due to rising incidence of various types of cancer and metabolic diseases requiring advanced therapies, presence of large number of Contract Manufacturing Organization in the region. For instance, according to the GLOBOCAN 2018, around 4,229,662 new cancer cases were reported in Europe. The market in Asia Pacific is projected to register a comparatively high CAGR during the forecast period. Increasing number of Contract Manufacturing Organization getting regulatory certifications from the western authorities, presence of skilled manpower, low cost of manufacturing, and high quality of products being manufactured are major factors projected to drive the Asia Pacific CMO market growth during the forecast period. The market in Latin America and the Middle East & Africa are currently in a nascent stage. However, the developing healthcare infrastructure in these regions and underlying development of regulatory standards in the countries such as Brazil, Mexico, Peru, and South Africa will boost the Contract Manufacturing Organization market growth during the forecast period in these regions.


KEY INDUSTRY PLAYERS


Services Offered at Competitive Pricing, Streamlined Business Relationships, and Improved Service Qualities to Drive the Demand


The competitive landscape of pharmaceutical Contract Manufacturing Organization (CMO) market indicates currently the market is highly fragmented. However, a strong emphasis on partnerships and acquisition strategies is likely to help boost Contract Manufacturing Organization (CMO) market revenue growth in the forthcoming years. The consolidation of the market has been observed as key trend of the market.


LIST OF KEY COMPANIES PROFILED:



  • Catalent Inc.

  • Recipharm AB

  • Jubilant Life Science Ltd

  • Lonza Group AG

  • Boehringer Ingelheim International GmbH

  • Vetter Pharma-Fertigung GmbH & Co. KG

  • FAMAR Health Care Services

  • Dr. Reddy’s Laboratories Ltd. 

  • Almac Group

  • Other prominent players


KEY INDUSTRY DEVELOPMENTS:



  • September2017 –Catalent Inc. announced acquisition of Pharmica LLC, an integrated provider of drug substance and drug product manufacturing and related services

  • June 2017 – Lonza Group AG Acquired PharmaCell B.V., one of the most respected cell and gene contract manufacturer in Europe.


REPORT COVERAGE


An Infographic Representation of Contract Manufacturing Organization (CMO) Market

To get information on various segments, share your queries with us



The contract manufacturing organization (CMO) market report provides a detailed analysis of the market and focuses on key aspects such as leading companies and service types. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over the recent years.


To gain extensive insights into the market, Request for Customization


Report Scope & Segmentation





































 ATTRIBUTE



 DETAILS



Study Period



  2015-2026



Base Year



  2018



Forecast Period



  2019-2026



Historical Period



  2015-2017



Unit



  Value (USD billion)



Segmentation



By Type



  • API Manufacturing

    • Finished Formulation Manufacturing

    • Solid Dosage Forms

    • Injectables



  • Packaging



By Geography



  • North America (the U.S. and Canada)

  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)

  • Latin America (Brazil, Mexico, and the Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)



Frequently Asked Questions

Fortune Business Insights says that the global market size is worth USD 188.07 billion by 2026.

In 2018, the market value stood at USD 92.42 billion.

Growing at a CAGR of 9.4%, the market will exhibit steady growth in the forecast period (2019-2026).

API manufacturing segment is the leading segment in this market by type.

Growing demand for biologic products for the treatment of critical illness and increased num-ber of CMOs across globe

Catalent Inc., Recipharm AB, Jubilant Life Science Ltd, and Lonza Group AG are the top players in the Contract Manufacturing Organization market.

North America dominated the market share in 2018.

Consolidation of the market is the major trend observed in the CMO market

Contract Manufacturing Organization (CMO) Market Size, Share and Global Industry Trend Forecast till 2026
  • Apr, 2020
  • 2018
  • 2015-2018
  • 135

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X